This was the headline: NuGenerex Immuno-Oncology Submits Protocol, Data, and Manufacturing Information to FDA in Advance of the IND Submission.
It appears they submitted the info regarding pre-IND ...and will now submit the IND...that date was not given.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
-
-
-
-
-
-
-